Actualités 26.03.2024 Les Grands Titres de Suisse occidentale (Mars 2024) D’approches innovantes en matière de soins cardiaques et de plastiques durables à l’amélioration des thérapies pour les lésions de la moelle épin...
Actualités 29.02.2024 Les Grands Titres de Suisse occidentale (Février 2024) D’importantes avancées en matière de semi-conducteurs et de percées dans la recherche médicale à des avancées stratégiques dans les secteurs de l...
Actualités 30.01.2024 Les Grands Titres de Suisse occidentale (Janvier 2024) Des avancées révolutionnaires dans l’agroalimentaire et la robotique aux réformes économiques stratégiques en passant par la recherche pionnière ...
News 26.03.2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 29.02.2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Actualités 20.10.2023 Lonza s’agrandit pour fabriquer le vaccin pneumococcique conjugué de Vaxcyte Lonza et la société américaine Vaxcyte, spécialisée dans l’innovation vaccinale de stade clinique, ont annoncé le renforcement de leur partenaria...
News 30.01.2024 Top Stories from Western Switzerland (January 2024) From groundbreaking advancements in agrifood and robotics to strategic economic reforms and pioneering research in space and medicine, discover W...
Actualités 29.09.2023 Les Grands Titres de Suisse occidentale (Juillet-Septembre 2023) De l'élaboration de solutions éco-innovantes à des avancées pionnières dans les domaines de la technologie solaire, de la recherche sur le cancer...
News 20.10.2023 Lonza expands to manufacture Vaxcyte’s pneumococcal conjugate vaccine Lonza and US clinical-stage vaccine innovation company Vaxcyte have announced an expansion in their partnership to establish a global commercial ...
News 18.10.2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 29.09.2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 06.09.2023 ten23 health boosts sterile production capacity and introduces new quality control services Renowned for its expertise in sterile drug product manufacturing, Valais-based ten23 health is taking significant steps to expand its services an...
News 20.02.2023 Limula and CSEM collaborate to make cellular therapies more accessible To improve the accessibility of cellular therapies using automation, Limula has received support from the CSEM from the prototyping phase to the ...
News 21.06.2022 KBI Biopharma and Selexis open a new biologics manufacturing facility in Geneva KBI Biopharma and Selexis, both JSR Life Sciences companies, announced that an expanded, fully-integrated mammalian contract development and manu...
News 11.05.2022 Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the ...
Success stories 25.05.2023 Merck : “Switzerland offers attractive and stable conditions for international companies.“ Merck Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing faciliti...
News 07.10.2020 Firmenich inaugurates a new pilot plant and laboratory in Geneva Firmenich, the world’s largest privately-owned Perfume and Taste company, has announced the opening of its new biotechnology and naturals pilot p...